Empiriko’s proprietary Biomimiks™ in-vitro technology closely mirrors the in-vivo metabolism of liver enzymes (cytochrome P450), mimicking the structure and function of liver enzymes to predict metabolism patterns and profiles in humans. This technology assesses the liver’s metabolic reaction to drugs, food and environmental agents.
Applications of Biomimiks™ platform include:
Development of novel compounds
Redesign of existing compounds for new indications
and to minimize toxicity
Screening of active, inert and toxic metabolites
Personalized Diagnostics Platform
Empiriko’s Personalized Metabolic Fingerprint™ (PMF) device would provide clinical researchers, physicians and patients an effective means to assess early disease detection, dose optimization, drug-to-drug interactions, toxicity and other relevant clinical biomarkers in real-time. Using a patient’s drop of blood, this home-based PMF device provides two channels for assessment - chemical and biological: